|
|
The Body Covers: The 7th Conference on Retroviruses and Opportunistic Infections
Conference Summaries: Day Four
Wednesday, February 2, 2000
- Session 78 -- State of the Art Lecture: Critical Issues in Antiretroviral Therapy
Coverage by Seattle Treatment Education Project
- Session 82 -- Pediatric/Maternal-Fetal Treatment Issues
Coverage by Mark Holodniy, M.D.
- Session 83 -- Antiviral Therapy: New Drugs
Coverage by Paul Sax, M.D.
Coverage by Seattle Treatment Education Project
- Session 84 -- Issues in HIV-1 Infection in Women
Coverage by Melanie Thompson, M.D.
- Session 88 -- Maternal/Fetal and Pediatric Pharmacokinetics of Antiretroviral Therapy
Coverage by Mark Holodniy, M.D.
- Session 89 -- Resistance to Antiretroviral Drugs
Coverage by Paul Sax, M.D.
Coverage by Doug Ward, M.D.
Coverage by Rick Stryker, M.D., M.P.H.
- Session 93 -- Genotypic and Phenotypic Characterization of HIV for Therapeutic Decision-Making
Coverage by Mark Holodniy, M.D.
- Late Breaker Session 2 -- Documentation of HIV-1 Superinfection and Acceleration of Disease Progression
Coverage by Seattle Treatment Education Project
- Late Breaker Session 5 -- It Is Safe to Discontinue Secondary Prophylaxis for PCP in HIV-Infected Patients Treated with HAART
Coverage by Seattle Treatment Education Project
- Late Breaker Session 6 -- Pharmacokinetic Interactions between Protease Inhibitors and Selected HMG-CoA Reductase Inhibitors
Coverage by Seattle Treatment Education Project
- Late Breaker Session 7 -- A Randomized, Placebo-Controlled Trial of Saquinavir, Indinavir or Nelfinavir in Combination with Amprenavir, Abacavir, Efavirenz & Adefovir in Patients with PI Failure
Coverage by Seattle Treatment Education Project
- Late Breaker Session 10 -- Virologic and Immunologic Evaluation of Structured Treatment Interruptions in Patients Experiencing Long-term Virologic Failure
Coverage by Seattle Treatment Education Project
- Late Breaker Session 11 -- Structured Cyclic Antiretroviral Therapy Interruption in Chronic Infection May Induce Immune Responses Against HIV-1 Antigens Associated with Spontaneous Drop in Viral Load
Coverage by Seattle Treatment Education Project
|
Advertisement
|